CFO, Principal Financial Officer, COO, Executive Vice President
Mr. Keith W. Marshall, Ph.D. is Chief Financial Officer, Principal Financial Officer, Chief Operating Officer, Executive Vice President of the company. He was Chief Financial Officer and Head of Corporationrationrate Development since 2015 at Torque Therapeutics, where his responsibilities included finance, operations, human resources, corporate strategy and business development. He served as Managing Director and Advisor in Healthcare Investment Banking from 2012 to 2014 at GCA Savvian Advisors, where he provided strategic counsel to healthcare companies, and continued from 2014 to 2015 at TAG Healthcare Advisors under an alliance with GCA Savvian. Dr. Marshall was Managing Director from 2011 to 2012 at Sagent Advisors Managing Director, Cofounder, and Chief Financial Officer from 2008 to 2011 at Montgomery, Marshall Healthcare Partners Managing Director of Healthcare Investment Banking from 2003 to 2008 at Montgomery Co. and Associate in Healthcare Investment Banking from 2001 to 2003 at JPMorgan HQ with additional responsibilities at JPMorgan Partners
President Since 2017 MBAMarshall previously worked as a Research Associate from 1990 to 1993 at ImmuLogic Pharmaceutical Corporationrationrationration, where he performed research under a collaboration with Merck around inhibition of MHC Class II molecules for autoimmune disease therapy. He holds an M.B.A. with concentrations in Finance, Strategy, and Entrepreneurship from the University of Chicago ? Booth School of Business; a Ph.D. in Pharmaceutical Chemistry from the University of California, San Francisco; and an A.B. in Biology from Washington University in St. Louis.